首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Integrated traditional Chinese medicine improves acute pancreatitis via the downregulation of PRSS1 and SPINK1
【2h】

Integrated traditional Chinese medicine improves acute pancreatitis via the downregulation of PRSS1 and SPINK1

机译:中成药通过下调PRSS1和SPINK1改善急性胰腺炎

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Integrated traditional Chinese medicine (ITCM) is known to improve health in patients with acute pancreatitis (AP); however, the molecular mechanisms underlying this effect are unknown. AP is associated with the expression of PRSS1 and SPINK1. Thus, the present study aimed to investigate whether ITCM was able to ameliorate AP by regulating the expression levels of protein, serine 1 (PRSS1) and serine peptidase inhibitor, Kazal type 1 (SPINK1). A total of 100 AP patients were divided at random into two groups. The treatment group were treated externally with a herbal ITCM preparation, while the control group received a routine placebo treatment. The mRNA and protein expression levels of PRSS1 and SPINK1 were subsequently compared between the two groups. The results revealed that the health of the patients who had received ITCM improved significantly when compared with the control group patients (P<0.05). In addition, the expression levels of PRSS1 and SPINK1 were found to be lower in the treatment group when compared with the control group (P<0.05). Therefore, ITCM exhibited a significant therapeutic effect on AP and produced no side effects since the treatment was applied externally. ITCM may ameliorate AP by downregulating the expression of PRSS1 and SPINK1; thus, should be considered as a potential therapy for the development of drugs against AP.
机译:众所周知,综合中药(ITCM)可以改善急性胰腺炎(AP)患者的健康。但是,这种作用的分子机制尚不清楚。 AP与PRSS1和SPINK1的表达相关。因此,本研究旨在研究ITCM是否能够通过调节蛋白丝氨酸1(PRSS1)和丝氨酸肽酶抑制剂Kazal 1型(SPINK1)的表达水平来改善AP。将总共​​100名AP患者随机分为两组。治疗组采用草药ITCM制剂进行外部治疗,而对照组则接受常规安慰剂治疗。随后比较两组之间PRSS1和SPINK1的mRNA和蛋白表达水平。结果显示,与对照组相比,接受ITCM的患者的健康状况显着改善(P <0.05)。此外,与对照组相比,治疗组的PRSS1和SPINK1的表达水平较低(P <0.05)。因此,ITCM对AP表现出显着的治疗效果,并且由于治疗是从外部进行的,因此没有产生副作用。 ITCM可能通过下调PRSS1和SPINK1的表达来改善AP。因此,应被视为开发抗AP药物的潜在疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号